昭衍新药回购股份19万股 每股回购价17.1元至16.79元

财中社
31 Dec 2024

  昭衍新药(603127/06127)发布公告,披露截至2024年12月31日的股份变动情况。公告显示,公司在该日期的已发行股份(不包括库存股份)总数为6.28亿股,较前日减少19万股,减少幅度为0.03%。与此同时,库存股份的数量增加至269万股,总股份数保持在6.3亿股不变。

  在2024年12月31日,公司通过其他证券交易所回购了19万股,回购价格为每股17.1元至16.79元,总支付金额为328万元。此次回购股份计划是基于公司在相关规定下进行的,且未涉及任何拟注销股份。

  2024年前三季度,昭衍新药实现收入13.35亿元,归母净利润-7031万元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10